|
|
||||||||
a Cardiac Surgical Department and Echocardiography Department, Wuhan Asia Heart Hospital, JingHan Ave, #753, Wuhan 430022, China
b Department of Cardiothoracic Surgery, National Heart Centre, Singapore
(Email: zengxiangjun@sohu.com; xiangjunzeng@163.com; yeongphanglim@yahoo.com).
| The first 20% of the full text of this article appears below. |
To the Editor:
We write in reply to the comments raised by Dixit and colleagues [1]. All the patients who underwent this procedure were ruled out from having transcutaneous device closure by our cardiology colleagues. The reasons for not considering these patients for transcutaneous closure were (1) size of defect exceeding 25 mm, (2) presence of a deficient rim (especially a deficient aortic rim), and (3) complicated or fenestrated atrial septal defect (ASD). One of the key advantages of this method is the ability to implant large devices for large ASDs regardless of femoral vessel size.
As these patients were not candidates for transcutaneous closure, the second point raised by Dixit and colleagues [1] is not valid.
We believe that the advantages of this approach are:
This article has been cited by other articles:
![]() |
X. Wei, W. Yi, X. Xu, J. Zhang, J. Li, S. Yu, and D. Yi Transthoracic occlusion for secundum atrial septal defects unsuitable for transcatheter occlusion approach J. Thorac. Cardiovasc. Surg., July 1, 2011; 142(1): 113 - 119. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |